SLFN11 and cancer: This observation, independently confirmed in our cohort (ρ = –0.42, P = 0.0276, see Supplemental Figure 4B), could be explained by hypothesizing that HGSOC cases with lower cancer cellularity would, in general, have higher tumor immune cell infiltration, with consequently higher SLFN11 levels.